Head

Prof. Andrzej Bojarski

Prof. Andrzej Bojarski
e-mail: bojarski@if-pan.krakow.pl

Scientific degrees:

  • 1986–91 Jagiellonian University, Faculty of Chemistry; specialization: organic chemistry
  • 1991 M.Sc. – thesis: „Synthesis of biologically active 1,4-naphtochinones” in Department of Carbocyclic Compounds, Faculty of Chemistry, Jagiellonian University
  • 1996 Ph.D. – thesis: „Modeling of the interactions between arylpiperazine type ligands and 5-HT1A receptor” Faculty of Pharmacy, Collegium Medicum, Jagiellonian University
  • 2005 – habilitation – “1,2,3,4-Tetrahydroisoquinolines and 4-cyclohexyl-1-arylpiperazines as new subclasses of 5-HT1A receptor ligands; structure-activity and structure-intrinsic activity relationships studies” Faculty of Pharmacy, Collegium Medicum, Jagiellonian University
  • 2013 – full professor

Employment and positions:

  • 1.09.1991 – 30.11.1992 – assistant – Chair of Organic Chemistry, Medical Academy, Kraków
  • 1.12.1992 – 31.08.1993 – assistant – Dept. of Med. Chem., Institute of Pharmacology Polish Academy of Sciences
  • 1.09.1993 – 31.12.1996 – senior assistant, Dept. of Med. Chem. IP PAS
  • 1.01.1997 – 30.06.2006 – assistant professor, Dept. of Med. Chem. IP PAS
  • 1.07.2006 – 30.09.2010 – associate professor, Dept. of Med. Chem. IP PAS
  • 1.10.2010 – 30.09.2013 – professor IP-PAS
  • since 1.10.2013 – professor
  • 1.03.2003 – 30.06.2006 – acting Head of the Department of Medicinal Chemistry IP PAS
  • since 1.07.2006 – Head of the Department of Medicinal Chemistry IP PAS

 Grants:

  • from 01.11.2013 ‒ EXtention of academia-based PLATFORM to antidepressant hits discovery (PLATFORMex), Nr Pol-Nor/198887/73/2013
  • from 01.07.2013 ‒ Innovative therapies for neurodegenerative and neurodevelopmental diseases based on mGlu receptor allosteric modulators – Allosterix, NCBiR 178469, 2013-2015
  • from 2011 – Depression – Mechanisms – Therapy, co-financed by European Union from the European Fund of Regional Development (EFRD), WND-POIG.01.01.02-12-004/09-00, 2010-2013,
  • 2010–2013 ModAll. Allosteric modulation – new strategy in pharmacotherapy. Identification of the psychotropic roperties of glutamatergic receptor ligands of group III, co-financed by European Union from the European Fund of Regional Development (EFRD) WND-POIG.01.03.01-12-100/08, www.modall.pl,
  • 2010 – 2013 Prokog. Antagonists of 5-HT6 receptor as advanced antipsychotic drugs with pro-cognitive properties, co-financed by European Union from the European Fund of Regional Development (EFRD), UDAPOIG.01.03.01-12-063/09-02, www.prokog.pl
  • The search for new 5-HT6 and 5-HT7 receptor ligands a potential CNS agents MNiSW nr N405 671540, participant; 2011-05-17–2014-05-16; Collegium Medicum UJ, Faculty of Pharmacy
  • Creating an academia-based platform to discover substances acting on serotonergic or glutamatergic systems as potential new antidepressant or anxiolytic drugs PNRF-103-AI-1/07, task leader of the project, 01.06.2009–31.10.2011, coordinator: IP-PAS, partners: Tromsø University and National Medicines Institute, Warsaw (www.cns-platform.eu)
  • The search for new biologically active compounds with potentially psychotropic activity in group of monoaminergic receptor ligands MNiSW nr N N405 3784 37, participant; 2009-10-21–2012-10-20; Collegium Medicum UJ, Faculty of Pharmacy
  • Chemical and pharmacological studies in the group of 4-arylpiperazinealkyl-succinimide and hydantoin derivatives as potential anticonvulsant agents MNiSW nr N N405 298536, participant; 2009-05-07–2012-05-06; Collegium Medicum UJ, Faculty of Pharmacy
  • The search for new mGluR2 and mGluR3 ligands and their pharmacological characteristics MNiSW N N405 1846 35, participant, 10.2008–09.2011; IP-PAS
  • Synthesis and search for structural determinants of selectivity of long-chain arylpiperazinepyrimido[5,4-c]-quinoline derivatives for selected types of serotonin receptor MNiSW N 405 1656 33, participant, 10.2007–09.2009; Medical University of Łódź, Faculty of Pharmacy
  • The search for new 5-HT7 receptor ligands as potential antidepressants MNiSW nr 2 P05F 019 30, leader, 24/04/2006–23/04/2009; IP-PAS
  • Structural modifications of arylpiperazine and arylsulfonamide 5-HT7 receptor ligands in search for determinants of selectivity for 5-HT1A receptor subtype MNiSW nr N405 026 32/1743 leader (PhD grant); 22.03.2007–21.03.2008; IP-PAS

 Awards and Fellowships:

  • The Jędrzej Śniadecki Prize of the Division of Medicinal Sciences of the Polish Academy of Sciences (1993)
  • Fellowship for Young Researchers – Foundation for Polish Science (1995)
  • Prime Minister Award for Ph.D. thesis (1997)
  • Postdoc out-going fellowship – Foundation for Polish Science (1998)
  • Stanisław Biniecki Award – Pharmaceutical Research Institute (2006)
  • Award for the best publications in the Institute of Pharmacology PAS (2006)
  • Minister of Health Group Award for scientific publications (2008)
  • Minister of Health Group Award for scientific publications (2010)

Former heads of the Department